Solid lipid nanoparticles for ocular drug delivery

References

• Abdelbary, G., El-Gendy, N. (2008). Niosome-encapsulated gentamicin for ophthalmic controlled delivery. AAPS PharmSciTech. 9:740–7.
   PubMed Web of Science ®Google Scholar
• Almeida, A.J., Runge, S., Müller, R.H. (1997). Peptide-loaded solid lipid nanoparticles (SLN): influence of production parameters. Int J Pharm. 149:255–65.
   Web of Science ®Google Scholar
• Almeida, A.J., Souto, E. (2007). Solid lipid nanoparticles as a drug delivery system for peptides and proteins. Adv Drug Deliv Rev. 59:478–90.
   PubMed Web of Science ®Google Scholar
• Alonso, M.J., Alonso, M.J. (2004). Nanomedicines for overcoming biological barriers. Biomed Pharmacother. 58:168–72.
   PubMed Web of Science ®Google Scholar
• Araújo, J., Gonzalez, E., Egea, M.A., Garcia, M.L., Souto, E.B. (2009). Nanomedicines for ocular NSAIDs: safety on drug delivery. Nanomedicine: NBM, 5:394–401.
   PubMed Web of Science ®Google Scholar
• Attama, A.A., Müller-Goymann, C.C. (2007). Investigation of surface-modified solid lipid nanocontainers formulated with a heterolipid-templated homolipid. Int J Pharm. 334:179–89.
   PubMed Web of Science ®Google Scholar
• Attama, A.A., Reichl, S., Müller-Goymann, C.C. (2008). Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct. Int J Pharm. 355:307–13.
   PubMed Web of Science ®Google Scholar
• Attama, A.A., Reichl, S., Muller-Goymann, C.C. (2009). Sustained release and permeation of timolol from surface-modified solid lipid nanoparticles through bioengineered human cornea. Curr Eye Res. 34:698–705.
   PubMed Web of Science ®Google Scholar
• Attama, A.A., Schicke, B.C., Paepenmüller, T., Müller-Goymann, C.C. (2007). Solid lipid nanodispersions containing mixed lipid core and a polar heterolipid: characterization. Eur J Pharm Biopharm. 67:48–57.
   PubMed Web of Science ®Google Scholar
• Basaran, Ebru., Demirel, M., Sirmagul, B. and Yazan, Y. (2009). Cyclosporine-A incorporated cationic solid lipid nanoparticles for ocular drug delivery. J Microencapsul. 27:1–11.
   Google Scholar
• Boisseau, P., Kiparissides, C., Pavesio, A., Saxl, O. (2005). European technology platform on nanoMedicine—nanotechnology for health, vision paper and basis for a strategic research agenda for nanomedicine. European Commission: Office for Official Publications of the European Communities (Luxembourg), 39 pp. ISBN 92-79-02203-2 (keine IP).
   Google Scholar
• Bottari, F., Giannaccini, B., Cristofori, B., Saettone, M.F., Tellini, N. (1978). Semisolid ophthalmic vehicles. I—A study of eye irritation in albino rabbits of a series of gel-type aqueous bases. Farmaco—Edizione Pratica. 33:434–46.
   PubMedGoogle Scholar
• Bourlais, C.L., Acar, L., Zia, H., Sado, P.A., Needham, T., Leverge, R. (1998). Ophthalmic drug delivery systems—recent advances. Prog Retin Eye Res. 17:33–58.
   PubMed Web of Science ®Google Scholar
• Bunjes, H., Koch, M.H.J. (2005). Saturated phospholipids promote crystallization but slow down polymorphic transitions in triglyceride nanoparticles. J Contr Rel. 107:229–43.
   PubMed Web of Science ®Google Scholar
• Bunjes, H., Unruh, T. (2007). Characterization of lipid nanoparticles by differential scanning calorimetry, X-ray and neutron scattering. Adv Drug Deliv Rev. 59:379–402.
   PubMed Web of Science ®Google Scholar
• Bunjes, H., Westesen, K., Koch, M.H.J. (1996). Crystallization tendency and polymorphic transitions in triglyceride nanoparticles. Int J Pharm. 129:159–73.
   Web of Science ®Google Scholar
• Calvo, P., Thomas, C., Alonso, M.J., Vila Jato, J.L., Robinson, J. (1994). Study of the mechanism of interaction of poly-E-caprolactone with the cornea by confocal laser scanning microscopy. Int J Pharm. 103:283–91.
   Web of Science ®Google Scholar
• Carafa, M., Santucci, E., Alhaique, F., Coviello, T., Murtas, E., Riccieri, F.M., Lucania, G., Torrisi, M.R. (1998). Preparation and properties of new unilamellar non-ionic/ionic surfactant vesicles. Int J Pharm. 160:51–9.
   Web of Science ®Google Scholar
• Cavalli, R., Gasco, M.R., Chetoni, P., Burgalassi, S., Saettone, M.F. (2002). Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin. Int J Pharm. 238:241–5.
   PubMed Web of Science ®Google Scholar
• Cavalli, R., Zara, G.P., Caputo, O., Bargoni, A., Fundarò, A., Gasco, M.R. (2000). Transmucosal transport of tobramycin incorporated in SLN after duodenal administration to rats. Part I—a pharmacokinetic study. Pharmacol Res. 42:541–5.
   PubMed Web of Science ®Google Scholar
• Cavalli, R., Marengo, E., Rodriguez, L., Gascom, R. (1996). Effects of some experimental factors on the production process of solid lipid nanoparticles. Eur J Pharm Biopharm. 43:110–5.
   Google Scholar
• Chen, M.-L. (2008). Lipid excipients and delivery systems for pharmaceutical development: a regulatory perspective. Adv Drug Deliv Rev. 60:768–77.
   PubMed Web of Science ®Google Scholar
• Coleman, N.J., Craig, D.Q.M. (1996). Modulated temperature differential scanning calorimetry: a novel approach to pharmaceutical thermal analysis. Int J Pharm. 135:13–29.
   Web of Science ®Google Scholar
• Cortesi, R., Argnani, R., Esposito, E., Dalpiaz, A., Scatturin, A., Bortolotti, F., Lufino, M., Guerrini, R., Cavicchioni, G., Incorvaia, C., Menegatti, E., Manservigi, R. (2006). Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity. Int J Pharm. 317:90–100.
   PubMed Web of Science ®Google Scholar
• Debbage, P. (2009). Targeted drugs and nanomedicine: present and future. Curr Pharm Des. 15:153–72.
   PubMed Web of Science ®Google Scholar
• Del Pozo-Rodríguez, A., Delgado, D., Solinís, M.A., Gascón, A.R., Pedraz, J.L. (2008). Solid lipid nanoparticles for retinal gene therapy: transfection and intracellular trafficking in RPE cells. Int J Pharm. 360:177–83.
   PubMed Web of Science ®Google Scholar
• Domb, A.J. (1995). Long acting injectable oxytetracycline-liposphere formulations. Int J Pharm. 124:271–8.
   Web of Science ®Google Scholar
• Draize, J.H., Woodard, G., Calvery, H.O. (1944). Methods for the study of irritation and toxicity of substances applied topically to the skin and mucous membranes. J Pharmacol Exp Therapeut. 82:377–90.
   Web of Science ®Google Scholar
• Duvvuri, S., Majumdar, S., Mitra, A.K. (2003). Drug delivery to the retina: challenges and opportunities. Expert Opin Biol Ther. 3:45–56.
   PubMed Web of Science ®Google Scholar
• Franz, T.J. (1975). Percutaneous absorption on the relevance of in vitro data. J Investig Dermatol. 64:190–5.
   PubMed Web of Science ®Google Scholar
• Freitas, C., Müller, R.H. (1998). Spray-drying of solid lipid nanoparticles (SLN™). Eur J Pharm Biopharm. 46:145–51.
   PubMed Web of Science ®Google Scholar
• Freitas, C., Müller, R.H. (1999). Correlation between long-term stability of solid lipid nanoparticles (SLN™) and crystallinity of the lipid phase. Eur J Pharm Biopharm. 47:125–32.
   PubMed Web of Science ®Google Scholar
• Gaudana, R., Jwala, J., Boddu, S.H., Mitra, A.K., Gaudana, R., Boddu, S.H.S., Mitra, A.K. (2009). Recent perspectives in ocular drug delivery. Pharm Res. 26:1197–216.
   PubMed Web of Science ®Google Scholar
• Gill, P.S., Sauerbrunn, S.R., Reading, M. (1993). Modulated differential scanning calorimetry. J Therm Anal Calorim. 40:931–9.
   Web of Science ®Google Scholar
• Giunchedi, P., Conte, U., Chetoni, P., Saettone, M.F. (1999). Pectin microspheres as ophthalmic carriers for piroxicam: evaluation in vitro and in vivo in albino rabbits. Eur J Pharm Biopharm. 9:1–7.
   Web of Science ®Google Scholar
• Gokce, E.H., Sandri, G., Bonferoni, M.C., Rossi, S., Ferrari, F., Guneri, T., Caramella, C. (2008). Cyclosporine A loaded SLNs: evaluation of cellular uptake and corneal cytotoxicity. Int J Pharm. 364:76–86.
   PubMed Web of Science ®Google Scholar
• Gokce, E.H., Sandri, G., Egrilmez, S., Bonferoni, M.C., Guneri, T., Caramella, C. (2009). Cyclosporine A-loaded solid lipid nanoparticles: ocular tolerance and in vivo drug release in rabbit eyes. Curr Eye Res. 34:996–1003.
   PubMed Web of Science ®Google Scholar
• Hauss, D.J. (2007). Oral lipid-based formulations. Adv Drug Deliv Rev. 59:667–76.
   PubMed Web of Science ®Google Scholar
• Heiati, H., Tawashi, R., Phillips, N.C. (1998). Drug retention and stability of solid lipid nanoparticles containing azidothymidine palmitate after autoclaving, storage and lyophilization. J Microencapsul. 15:173–84.
   PubMed Web of Science ®Google Scholar
• Heiati, H., Tawashi, R., Shivers, R.R., Phillips, N.C. (1997). Solid lipid nanoparticles as drug carriers. I. Incorporation and retention of the lipophilic prodrug 3'-azido-3'-deoxythymidine palmitate. Int J Pharm. 146:123–31.
   Web of Science ®Google Scholar
• Helgason, T., Awad, T.S., Kristbergsson, K., McClements, D.J., Weiss, J. (2009). Effect of surfactant surface coverage on formation of solid lipid nanoparticles (SLN). J Colloid Interface Sci. 334:75–81.
   PubMed Web of Science ®Google Scholar
• Heydenreich, A.V., Westmeier, R., Pedersen, N., Poulsen, H.S., Kristensen, H.G. (2003). Preparation and purification of cationic solid lipid nanospheres—effects on particle size, physical stability and cell toxicity. Int J Pharm. 254:83–7.
   PubMed Web of Science ®Google Scholar
• Hironaka, K., Inokuchi, Y., Tozuka, Y., Shimazawa, M., Hara, H., Takeuchi, H. (2009). Design and evaluation of a liposomal delivery system targeting the posterior segment of the eye. J Contr Rel. 136:247–53.
   PubMed Web of Science ®Google Scholar
• Hornof, M., Toropainen, E., Urtti, A. (2005). Cell culture models of the ocular barriers. Eur J Pharm Biopharm. 60:207–25.
   PubMed Web of Science ®Google Scholar
• Hou, D., Xie, C., Huang, K., Zhu, C. (2003). The production and characteristics of solid lipid nanoparticles (SLNs). Biomaterials. 24:1781–5.
   PubMed Web of Science ®Google Scholar
• Hu, F.Q., Hong, Y., Yuan, H. (2004). Preparation and characterization of solid lipid nanoparticles containing peptide. Int J Pharm. 273:29–35.
   PubMed Web of Science ®Google Scholar
• Hu, F.-Q., Jiang, S.-P., Du, Y.-Z., Yuan, H., Ye, Y.-Q., Zeng, S. (2005). Preparation and characterization of stearic acid nanostructured lipid carriers by solvent diffusion method in an aqueous system. Colloids Surf B Biointerfaces. 45:167–73.
   PubMed Web of Science ®Google Scholar
• Hu, F.Q., Yuan, H., Zhang, H.H., Fang, M. (2002). Preparation of solid lipid nanoparticles with clobetasol propionate by a novel solvent diffusion method in aqueous system and physicochemical characterization. Int J Pharm. 239:121–8.
   PubMed Web of Science ®Google Scholar
• Jannin, V., Musakhanian, J., Marchaud, D. (2008). Approaches for the development of solid and semi-solid lipid-based formulations. Adv Drug Deliv Rev. 60:734–46.
   PubMed Web of Science ®Google Scholar
• Janoria, K.G., Hariharan, S., Dasari, C.R., Mitra, A.K. (2007). Recent patents and advances in ophthalmic drug delivery. Recent Patents Drug Deliv Formul. 1:161–70.
   PubMedGoogle Scholar
• Jenning, V., Mäder, K., Gohla, S.H. (2000). Solid lipid nanoparticles (SLN(TM)) based on binary mixtures of liquid and solid lipids: a 1H-NMR study. Int J Pharm. 205:15–21.
   PubMed Web of Science ®Google Scholar
• Kaur, I.P., Garg, A., Singla, A.K., Aggarwal, D. (2004). Vesicular systems in ocular drug delivery: an overview. Int J Pharm. 269:1–14.
   PubMed Web of Science ®Google Scholar
• Kaur, I.P., Kanwar, M., Kaur, I.P., Kanwar, M. (2002). Ocular preparations: the formulation approach. Drug Dev Ind Pharm. 28:473–93.
   PubMed Web of Science ®Google Scholar
• Kaur, I.P., Rana, C., Singh, H. (2008). Development of effective ocular preparations of antifungal agents. J Ocul Pharmacol Therapeut. 24:481–93.
   PubMed Web of Science ®Google Scholar
• Küchler, S., Radowski, R.M., Haag, R., Schäfer-Korting, M. (2008). Comparison of solid lipid nanoparticles and dendritic core-multishell nanoparticles as drug delivery systems for topical application. European Workshop on Particulate Systems, Berlin.
   Google Scholar
• Kuo, Y.-C., Chen, H.-H. (2009). Entrapment and release of saquinavir using novel cationic solid lipid nanoparticles. Int J Pharm. 365:206–13.
   PubMed Web of Science ®Google Scholar
• Law, S.L., Huang, K.J., Chiang, C.H. (2000). Acyclovir-containing liposomes for potential ocular delivery: corneal penetration and absorption. J Contr Rel. 63:135–40.
   PubMed Web of Science ®Google Scholar
• Lherm, C., Müller, R.H., Puisieux, F., Couvreur, P. (1992). Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length. Int J Pharm. 84:13–22.
   Web of Science ®Google Scholar
• Li, X., Lin, X., Zheng, L., Yu, L., Lv, F., Zhang, Q., Liu, W. (2008a). Effect of poly(ethylene glycol) stearate on the phase behavior of monocaprate/Tween80/water system and characterization of poly(ethylene glycol) stearate-modified solid lipid nanoparticles. Colloid Surf Physicochem Eng Aspect. 317:352–9.
   Web of Science ®Google Scholar
• Li, X., Nie, S.-F., Kong, J., Li, N., Ju, C.-Y., Pan, W.-S. (2008b). A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int J Pharm. 363:177–82.
   PubMed Web of Science ®Google Scholar
• Lin, X., Li, X., Zheng, L., Yu, L., Zhang, Q., Liu, W. (2007). Preparation and characterization of monocaprate nanostructured lipid carriers. Colloid Surf A Physicochem Eng Aspects. 311:106–11.
   Web of Science ®Google Scholar
• Liu, X., Zhang, Y., Tang, X., Zhang, H. (2009). Determination of entrapment efficiency and drug phase distribution of submicron emulsions loaded silybin. J Microencapsul. 26:180–6.
   PubMed Web of Science ®Google Scholar
• Liu, Z., Pan, W., Nie, S., Zhang, L., Yang, X., Li, J. (2005). Preparation and evaluation of sustained ophthalmic gel of enoxacin. Drug Dev Ind Pharm. 31:969–75.
   PubMed Web of Science ®Google Scholar
• Lv, Q., Yu, A., Xi, Y., Li, H., Song, Z., Cui, J., Cao, F., Zhai, G. (2009). Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery. Int J Pharm. 372:191–8.
   PubMed Web of Science ®Google Scholar
• Mainardes, R.M., Urban, M.C.C., Cinto, P.O., Khalil, N.M., Chaud, M.V., Evangelista, R.C., Daflon Gremiao, M.P. (2005). Colloidal carriers for ophthalmic drug delivery. Curr Drug Target. 6:363–71.
   PubMed Web of Science ®Google Scholar
• Marengo, E., Cavalli, R., Caputo, O., Rodriguez, L., Gasco, M.R. (2000). Scale-up of the preparation process of solid lipid nanospheres. Part I. Int J Pharm. 205:3–13.
   PubMed Web of Science ®Google Scholar
• Mehnert, W., Mäder, K. (2001). Solid lipid nanoparticles: production, characterization and applications. Adv Drug Deliv Rev. 47:165–96.
   PubMed Web of Science ®Google Scholar
• Meisner, D., Mezei, M. (1995). Liposome ocular delivery systems. Adv Drug Deliv Rev. 16:75–93.
   Web of Science ®Google Scholar
• Moshfeghi, A.A., Peyman, G.A. (2005). Micro- and nanoparticulates. Adv Drug Deliv Rev. 57:2047–52.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., Lucks, J.S. (1996). Arzneistoffträger aus festen Lipidteilchen-Feste Lipid Nanosphären (SLN), European patent EP 0 605 497 B1.
   Google Scholar
• Müller, R.H., Mäder, K., Gohla, S. (2000). Solid lipid nanoparticles (SLN) for controlled drug delivery—a review of the state of the art. Eur J Pharm Biopharm. 50:161–77.
   PubMed Web of Science ®Google Scholar
• Müller, R.H., Radtke, M., Wissing, S.A. (2002). Nanostructured lipid matrices for improved microencapsulation of drugs. Int J Pharm. 242:121–8.
   PubMed Web of Science ®Google Scholar
• Nagarwal, R.C., Kant, S., Singh, P.N., Maiti, P., Pandit, J.K. (2009). Polymeric nanoparticulate system: a potential approach for ocular drug delivery. J Contr Rel. 136:2–13.
   PubMed Web of Science ®Google Scholar
• Nilüfer, Y., Aysegül, K., Yalcin, O., Ayhan, S., Sibel, A.O., Tamer, B. (2003). Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol in vitro and in vivo evaluation. Eur J Pharm Biopharm. 56:453–9.
   PubMed Web of Science ®Google Scholar
• Olbrich, C., Bakowsky, U., Lehr, C.-M., Müller, R.H., Kneuer, C. (2001). Cationic solid-lipid nanoparticles can efficiently bind and transfect plasmid DNA. J Contr Rel. 77:345–55.
   PubMed Web of Science ®Google Scholar
• Pardeike, J., Hommoss, A., Müller, R. H. (2009). Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 366:170–84.
   PubMed Web of Science ®Google Scholar
• Pouton, C.W., Porter, C.J.H. (2008). Formulation of lipid-based delivery systems for oral administration: materials, methods and strategies. Adv Drug Deliv Rev. 60:625–37.
   PubMed Web of Science ®Google Scholar
• Radomska-Soukharev, A. (2007). Stability of lipid excipients in solid lipid nanoparticles. Adv Drug Deliv Rev. 59:411–8.
   PubMed Web of Science ®Google Scholar
• Reichl, S., Bednarz, J., Muller-Goymann, C.C. (2004). Human corneal equivalent as cell culture model for in vitro drug permeation studies. B J Ophthalmol. 88:560–5.
   PubMed Web of Science ®Google Scholar
• Reichl, S., Döhring, S., Bednarz, J., Müller-Goymann, C.C. (2005). Human cornea construct HCC—an alternative for in vitro permeation studies? A comparison with human donor corneas. Eur J Pharm Biopharm. 60:305–8.
   PubMed Web of Science ®Google Scholar
• Ronald, D.S., Hong-Shian, H. (1983). Corneal penetration behavior of beta-blocking agents I: physicochemical factors. J Pharm Sci. 72:1266–72.
   PubMed Web of Science ®Google Scholar
• Sahoo, S.K., Dilnawaz, F., Krishnakumar, S. (2008). Nanotechnology in ocular drug delivery. Drug Discov Today. 13:144–51.
   PubMed Web of Science ®Google Scholar
• Sawant, K.K., Dodiya, S.S. (2008). Recent advances and patents on solid lipid nanoparticles. Recent Patents Drug Deliv Formulation. 2:120–35.
   PubMedGoogle Scholar
• Schwarz, C., Mehnert, W. (1997). Freeze-drying of drug-free and drug-loaded solid lipid nanoparticles (SLN). Int J Pharm. 157:171–9.
   PubMed Web of Science ®Google Scholar
• Seal, D.V., Bron, A.J., Hay, J. (1998). Ocular infection; investigation and treatment in practice., London: Martin Dunitz Ltd.
   Google Scholar
• Shen, J., Sun, M., Ping, Q., Ying, Z., Liu, W. (2010). Incorporation of liquid lipid in lipid nanoparticles for ocular drug delivery enhancement. Nanotechnology. 21:1–10.
   Web of Science ®Google Scholar
• Shen, J., Wang, Y., Ping, Q., Xiao, Y., Huang, X. (2009). Mucoadhesive effect of thiolated PEG stearate and its modified NLC for ocular drug delivery. J Contr Rel. 137:217–23.
   PubMed Web of Science ®Google Scholar
• Sjöström, B., Bergenståhl, B. (1992). Preparation of submicron drug particles in lecithin-stabilized o/w emulsions I. Model studies of the precipitation of cholesteryl acetate. Int J Pharm. 88:53–62.
   Web of Science ®Google Scholar
• Souto, E.B., Mehnert, W., Müller, R.H. (2006). Polymorphic behaviour of Compritol 888® ATO as bulk lipid and as SLN and NLC. J Microencapsul. 23:417–33.
   PubMed Web of Science ®Google Scholar
• Souto, E.B., Wissing, S.A., Barbosa, C.M., Müller R.H. (2004). Development of a controlled release formulation based on SLN and NLC for topical clotrimazole delivery. Int J Pharm. 278:71–7.
   PubMed Web of Science ®Google Scholar
• Trotta, M., Cavalli, R., Carlotti, M.E., Battaglia, L., Debernardi, F. (2005). Solid lipid micro-particles carrying insulin formed by solvent-in-water emulsion-diffusion technique. Int J Pharm. 288:281–8.
   PubMed Web of Science ®Google Scholar
• Trotta, M., Debernardi, F., Caputo, O. (2003). Preparation of solid lipid nanoparticles by a solvent emulsification-diffusion technique. Int J Pharm. 257:153–60.
   PubMed Web of Science ®Google Scholar
• Uchegbu, I.F., Vyas, S.P. (1998). Non-ionic surfactant based vesicles (niosomes) in drug delivery. Int J Pharm. 172:33–70.
   Web of Science ®Google Scholar
• Urtti, A. (2006). Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev. 58:1131–5.
   PubMed Web of Science ®Google Scholar
• Urtti, A., Salminen, L. (1993). Minimizing systemic absorption of topically administered ophthalmic drugs. Surv Ophthalmol. 37:435–56.
   PubMed Web of Science ®Google Scholar
• Vandamme, T.F. (2002). Microemulsions as ocular drug delivery systems: recent developments and future challenges. Progr Retin Eye Res. 21:15–34.
   PubMed Web of Science ®Google Scholar
• Velpandian, T., Velpandian, T. (2009). Intraocular penetration of antimicrobial agents in ophthalmic infections and drug delivery strategies. Expert Opin Drug Deliv. 6:255–70.
   PubMed Web of Science ®Google Scholar
• Vighi, E., Ruozi, B., Montanari, M., Battini, R., Leo, E. (2007). Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid. Eur J Pharm Biopharm. 67:320–8.
   PubMed Web of Science ®Google Scholar
• Vyas, S.P., Rai, S., Paliwal, R., Gupta, P.N., Khatri, K., Goyal, A.K., Vaidya, B. (2008). Solid lipid nanoparticles (SLNs) as a rising tool in drug delivery science: one step up in nanotechnology. Curr Nanosci. 4:30–44.
   Web of Science ®Google Scholar
• Wadhwa, S., Paliwal, R., Paliwal, S.R., Vyas, S.P. (2009). Nanocarriers in ocular drug delivery: an update review. Curr Pharm Des. 15:2724–50.
   PubMed Web of Science ®Google Scholar
• Westesen, K., Bunjes, H. (1995). Do nanoparticles prepared from lipids solid at room temperature always possess a solid lipid matrix? Int J Pharm. 115:129–31.
   Web of Science ®Google Scholar
• Westesen, K., Bunjes, H., Koch, M.H.J. (1997). Physicochemical characterization of lipid nanoparticles and evaluation of their drug loading capacity and sustained release potential. J Contr Rel. 48:223–36.
   Web of Science ®Google Scholar
• Westesen, K., Siekmann, B. (1997). Investigation of the gel formation of phospholipid-stabilized solid lipid nanoparticles. Int J Pharm. 151:35–45.
   Web of Science ®Google Scholar
• Wissing, S.A., Kayser, O., Müller, R.H. (2004). Solid lipid nanoparticles for parenteral drug delivery. Adv Drug Deliv Rev. 56:1257–72.
   PubMed Web of Science ®Google Scholar
• Yasukawa, T., Kimura, H., Tabata, Y., Ogura, Y. (2001). Biodegradable scleral plugs for vitreoretinal drug delivery. Adv Drug Deliv Rev. 52:25–36.
   PubMed Web of Science ®Google Scholar
• Yun, J., Zhang, S., Shen, S., Chen, Z., Yao, K., Chen, J. (2009). Continuous production of solid lipid nanoparticles by liquid flow-focusing and gas displacing method in microchannels. Chem Eng Sci. 64:4115–22.
   Web of Science ®Google Scholar
• Zhang, S.-H., Shen, S.-C., Chen, Z., Yun, J.-X., Yao, K.-J., Chen, B.-B., Chen, J.-Z. (2008). Preparation of solid lipid nanoparticles in co-flowing microchannels. Chem Eng Sci. 144:324–8.
   Web of Science ®Google Scholar
• Zimmer, A., Kreuter, J. (1995). Microspheres and nanoparticles used in ocular delivery systems. Adv Drug Deliv Rev. 16:61–73.
   Web of Science ®Google Scholar
• Zimmermann, E., Müller, R.H., Mäder, K. (2000). Influence of different parameters on reconstitution of lyophilized SLN. Int J Pharm. 196:211–3.
   PubMed Web of Science ®Google Scholar
• Zur Mühlen A., Schwarz, C., Mehnert, W. (1998). Solid lipid nanoparticles (SLN) for controlled drug delivery—drug release and release mechanism. Eur J Pharm Biopharm. 45:149–55.
   PubMed Web of Science ®Google Scholar